Itaconix widens loss after exiting nicotine gum business

Josh White Sharecast | 27 Mar, 2017 15:34 | | |




17:16 28/04/17
  • 12,975.83
  • -0.72%-94.10
  • Max: 13,145.28
  • Min: 12,968.70
  • Volume: 0
  • MM 200 : n/a
17:20 28/04/17
  • 963.72
  • 0.20%1.88
  • Max: 964.37
  • Min: 961.35
  • Volume: 0
  • MM 200 : n/a
17:20 28/04/17

Itaconix posted its preliminary results for the 12 months to 31 December on Monday - a year in which it changed its name from Revolymer, and undertook a “major reorganisation” to focus on its specialty chemicals business.

The AIM-traded firm reported £8.8m of short term deposits, cash and cash equivalents on hand at the year end, down from £10.5m.

Its financial reporting for the year was split into continuing operations - specialty chemicals including the US business of Itaconix Corporation acquired in June 2016 - and its discontinued nicotine gum operations.

Continuing operations revenue was £0.3m, up from nil a year earlier, primarily thanks to the Itaconix DSPTM product, resulting in a gross profit of £0.1m, also rising from nil.

Administrative expenses on continuing operations - including research and development expenditure - was £5.3m, up from £2.7m.

The increase of £2.6m was explained by the board by an increase in non cash charges relating mainly to the acquisition of Itaconix of £1.0m, £0.3m of costs not expected to be recurring, the cost of running the new US business including research and development of £0.6m, additional UK staff costs including research and development of £0.3m, additional other development costs of £0.1m, and additional advisory - including external finance and audit - costs of £0.1m.

As a result, the group’s operating loss before tax was £5.2m, widening from £2.6m, with the difference mainly accounted for by the increase in administrative expenses, half of which were non-cash or non-recurring.

Continuing operations’ total loss for the year widened to £5.1m from £0.7m, after research and development tax credits of £0.5m and a share of the loss of an associate of £0.5m.

“The group now has a portfolio of specialty products to supply to its customers in its key market segments of personal care, homecare and industrial,” said chief executive officer Kevin Matthews.

“All of these segments are global in nature, consistently delivering high growth rates and attractive margins.

“There are significant benefits to a product based business versus a licence only model including greater customer intimacy, more control over execution timelines and greater margin potential.”

Dr Matthews described Itaconix as an “innovator”, developing new products to meet customer needs.

“As well as having expertise in designing novel polymer products that can be protected with patents and know-how, the business has also developed application and formulation expertise that provides better insights into how polymers can be used to provide cost effective solutions for its customers.

“Itaconix is engaged in building a high margin, capital efficient business.

“Except for its relatively low cost polyitaconate manufacturing facility, the business uses third party contract manufacturers for a number of its products.”

More news

28 Apr S&P reaffirms AA rating on UK, outlook clouded by Brexit

Standard&Poor's reaffirmed its rating on the United Kingdom's long-term sovereign debt but warned of the potential impact on the economy from the uncertainty around the Brexit negotiations and their eventual outcome.

28 Apr FX round-up: Sterling nonchalant after UK Q1 growth disappoints

Sterling made steady gains on most key cross on Friday, appearing nonchalant in its reaction to disappointing UK economic growth data out mid-morning.

28 Apr Europe close: Weak US, UK GDP weigh on shareson the continent

European stocks ended the day on a mixed note after weak readings on UK and US GDP dragged many indices into the red at the end of the month.

28 Apr Laird off to solid start, but second half remains key

Electronic component maker Laird reported strong sales growth in the first quarter of 2017 after a difficult year.

28 Apr General Motors truck and SUV sales drive record earnings

Growth at General Motors accelerated past analyst forecasts with a record first-quarter set of earnings.

28 Apr RBS and Lloyds Bank customers hit by online glitch on payday

Royal Bank of Scotland and Lloyds Banking Group customers were prevented from accessing money in their accounts due to a technical glitch ahead of the bank holiday weekend.

28 Apr Kennedy Wilson confirms quarterly dividend, new office leases

Kennedy Wilson Europe Real Estate announced it will pay an interim quarterly dividend of 12.0p per share, while also reporting strong leasing momentum across key investments in Greater London and Dublin.

28 Apr Time spins backwards on decision not to sell business

Time Inc stock reversed recent gains after the board decided not to sell the publishing business as it was being "reinvigorated" under a new strategy.

28 Apr Morgan Stanley downgrades Berendsen on competition concerns

Berendsen not only needs to invest in property, plant and equipment but is facing increasing competition in the UK, warned Morgan Stanley as it downgraded the stock on Friday.

28 Apr UK mortgages and consumer credit card borrowing both decline - BBA

Mortgage approvals and consumer credit card lending both fell in March according to fresh data from the banking industry, providing the reason for the fall in house prices announced elsewhere on Friday.